Medicine and Dentistry
Interstitial Lung Disease
100%
Patient
54%
Rheumatoid Arthritis
45%
Epitope
45%
Antibody
36%
Smoking
36%
Rheumatoid Factor
36%
Peptide
27%
Erythrocyte Sedimentation Rate
27%
DAS28
27%
Association
18%
Biological Product
9%
Logistic Regression Analysis
9%
Disease Severity
9%
Methotrexate
9%
Prednisone
9%
Subcutaneous Nodule
9%
Age
9%
Analysis
9%
Joint
9%
Assessment
9%
Environmental Factor
9%
Rheumatology
9%
Clinical Genetics
9%
Swelling
9%
Nursing and Health Professions
Interstitial Lung Disease
100%
Rheumatoid Arthritis
45%
Epitope
45%
Antibody
36%
Rheumatoid Factor
36%
Peptide
27%
Erythrocyte Sedimentation Rate
27%
DAS28
27%
Male
18%
Biological Product
9%
Comorbidity
9%
Disease Severity
9%
Prednisone
9%
Laboratory
9%
Time
9%
Procedures
9%
Analysis
9%
Methotrexate
9%
Subcutaneous Nodule
9%
Swelling
9%
Immunology and Microbiology
Lung
100%
Epitope
45%
Inflammatory Arthritis
45%
Monospecific Antibody
36%
Rheumatoid Factor
36%
Erythrocyte Sedimentation Rate
27%
Joint
18%
Association
18%
Comorbidity
9%
Biological Product
9%
Titer
9%
Prednisone
9%
Methotrexate
9%
Age
9%
Time
9%
Veterinary Science and Veterinary Medicine
Rheumatoid Arthritis
45%
Prednisone
9%
Methotrexate
9%